The pharmaceutical, biotechnology, and life science industries demand the highest levels of precision, safety, and innovation. Protecting both products and personnel is a top priority. Lugaia, a brand known for its Swiss precision and advanced technology, provides customized single-use containment solutions that meet these essential needs. The head of sales, Michael Schweizer, discussed details of the company's participation in Ipack Ima, providing an overview of future market trends.

Swiss Precision and Cutting-Edge Technology at Pharmintech 2025

«From the initial concept to the final product, Lugaia employs industry expertise and ergonomic studies to ensure their solutions are not only effective but also user-friendly» declared Mr Schweizer. «Whether it’s flexible packaging, complex isolator systems, or innovative transfer solutions, Lugaia’s products are engineered to provide optimal protection for both products and personnel. The use of Lugaia's continuous liner systems have proven to be one of the most effective means for protecting staff and products. Axial folding enables film lengths of up to 80 meters. Continuous liner carriers form the interface between the outlet and the continuous liner package, resulting in industry-appropriate handling and protection. These systems are essential in various industries such as pharmaceuticals, biotechnology, and chemicals, where containment and cleanliness are crucial. Moreover, to ensure effective sealing and separation, the continuous liner utilizes Lugaia's patented SafeSeal Closure System. This advanced system guarantees an OEB 5 containment level (<1μg/m³), providing the highest level of protection.»

Moreover, looking at complex isolator systems, the manager continued: «For applications requiring the highest levels of containment, Lugaia’s complex isolator systems creates a controlled environment that protects both the product and the operator from exposure to hazardous materials. Lugaia’s isolators are tailored to local requirements regarding dimensions, connectivity and ergonomics, ensuring they are safe and comfortable to use. A well-designed, flexible containment isolator offers protection similar to a stainless-steel isolator and provides various advantages depending on the application. This is particularly beneficial for smaller product quantities, frequent product changes, and common changes in process steps. Flexible containment can be quickly modified and adapted to specific needs, saving time and money. Safe and efficient material transfer is crucial in the life science and pharmaceuticals industries. Lugaia’s transfer solutions are designed to facilitate smooth, safe movement of small quantities of powder within controlled environments. Transfer bags can be made of customer-specific foil and are available in cleanroom classes ISO 5, ISO 7 and ISO 8. Custom designs with various connection options are also available. These solutions minimize contamination and exposure risks, protecting both the product and the personnel involved in the transfer process. Lugaia’s transfer systems are engineered to be reliable and easy to use, ensuring materials can be handled quickly and safely.»

Showcasing Lugaia’s commitment to safety and Innovation

«Lugaia’s dedication to safety and innovation is evident in every aspect of the business» Mr Schweizer went on.  «The containment systems meet the highest safety standards, ensuring the protection of both products and personnel. By integrating the latest technological advancements and industry expertise, Lugaia continually pushes the boundaries in containment solutions. The upcoming release of the new high containment single-use charge bag at the end of the year highlights Lugaia’s commitment to providing the highest levels of safety and efficiency and shows Lugaia’s innovative spirit. This product aims to improve the handling of hazardous materials, offering a faster, easier and safer solution for the industry.
The groundbreaking new product will be showcased at the Lugaia booth at Pharmintech, from May 27-30, 2025 in Milan.

What is your view on the market and future developments?

«At Lugaia, we are excited about the rapid technological and innovative advancements in our market» stated Mr Schweizer as the conversation drew to an end. «One notable trend in the pharmaceutical industry is the development of increasingly potent active ingredients. This advancement necessitates higher containment levels to ensure safety and prevent contamination. As these substances become more powerful, stricter regulations and enhanced containment measures are required to protect both the environment and the health of individuals handling these compounds. In brief, following the above considerations the key market developments are focused on:

•            Automation and robotics: revolutionizing cleanrooms by enhancing precision, reducing human error, and increasing efficiency.

•            Material innovations: advancing towards more durable, chemical-resistant, and cleaner products that promote sustainability.

•            Digital transformation: developing digital tools to enable real-time monitoring and control and data analytics and machine learning to drive continuous improvement.

•            Sustainability: using biodegradable materials and energy-efficient processes to minimize environmental impact.

•            Customer-centric innovation: developing tailored solutions by working closely with customers to remain a trusted partner in flexible containment solutions.